Gastroresistant Formulation
Gastroresistant Formulation is a pharmaceutical dosage form designed to remain intact in the acidic environment of the stomach and to release its active ingredient only upon reaching the higher pH of the intestinal tract, thereby preventing gastric degradation and minimizing gastric irritation.
24
Publications
824
Citations
156
Authors
60
Institutions
Publications per year
2017–2026
11
Variants
Enteric Dosage FormEnteric FormulationGastroresistant Dosage Form
Parents
24
Carmela Colica, Laura Di Renzo, Domenico Trombetta et al. · Oxidative Medicine and Cellular Longevity · 2017 · 88 citations · Full text
J. Theodore Phillips, Krzysztof Selmaj, Ralf Gold et al. · International Journal of MS Care · 2015 · 60 citations · Full text
Pharmacy, Neurology, Pharmacotherapy +13
Eudragit S100 Entrapped Liposome for Curcumin Delivery: Anti-Oxidative Effect in Caco-2 Cells
Vincenzo De Leo, Sante Di Gioia, Francesco Milano et al. · Coatings · 2020 · 59 citations · Full text
1–5 of 24
156
2
h-index
Universidade Estadual de Campinas (UNICAMP), Brazil
1 publications · 31 citations
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 156
60
Universidad de la República de Uruguay
Montevideo, Uruguay
1 h-index
6 publications
90 citations

Università di Camerino
Camerino, Italy
1 h-index
4 publications
144 citations

UNSW Sydney
Sydney, Australia
1 h-index
3 publications
66 citations
Institute of Sciences of Food Production
Bari, Italy
1 h-index
2 publications
118 citations
Politecnico di Milano
Milan, Italy
1 h-index
1 publications
49 citations

University of Milan
Milan, Italy
1 h-index
9 publications
441 citations
Azienda Ospedaliero Universitaria Maggiore della Carita
Novara, Italy
1 h-index
5 publications
270 citations
Université Paris-Sud
Orsay, France
1 h-index
1 publications
19 citations
1–8 of 60
4 publications · 112 citations
4
h-index
2 publications · 22 citations
2
h-index
2 publications · 80 citations
2
h-index
1 publications · 54 citations
1
h-index
1 publications · 16 citations
1
h-index
1–5